Titan Pharmaceuticals
TTNP
#10412
Rank
ยฃ4.58 M
Marketcap
ยฃ3.45
Share price
-3.76%
Change (1 day)
26.78%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -ยฃ3.38

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ3.28. In 2023 the company made an earnings per share (EPS) of -ยฃ5.54 an increase over its 2022 EPS that were of -ยฃ11.35.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ3.38
2023-ยฃ5.54-51.22%
2022-ยฃ11.35-15.61%
2021-ยฃ13.45-81.37%
2020-ยฃ72.21-77.52%
2019-ยฃ321.27-56.32%
2018-ยฃ735.53-59.51%
2017-ยฃ1,817-371.81%
2016ยฃ668.39-144.35%
2015-ยฃ1,507300%
2014-ยฃ376.73-121.54%
2013ยฃ1,749-151.38%
2012-ยฃ3,404-11.54%
2011-ยฃ3,848188.89%
2010-ยฃ1,332-10%
2009-ยฃ1,480
2007-ยฃ6,068-2.38%
2006-ยฃ6,216-39.13%
2005-ยฃ10,212-16.87%
2004-ยฃ12,284-22.43%
2003-ยฃ15,8364.9%
2002-ยฃ15,09661.9%
2001-ยฃ9,324-13.7%
2000-ยฃ10,80465.01%
1999-ยฃ6,548-35.87%
1998-ยฃ10,210-1824.71%
1997ยฃ592.01-102.4%
1996-ยฃ24,716

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-ยฃ1.06-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ0.18-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ2.53-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.80-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.50-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
ยฃ0.02242-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA